STOCK TITAN

Cineverse Corp. Form 4 Filings

CNVS NASDAQ

Every Form 4 that Cineverse Corp. (CNVS) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow CNVS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CNVS filings page.

Rhea-AI Summary

Cineverse Corp. (CNVS) reported that officer Mark Antonio Huidor, President of Technology and Chief Product Officer, sold 15,000 shares of Class A common stock on August 19, 2026 at a weighted average price of $2.68 per share, with individual trades between $2.64 and $2.70. Following the sale, he directly holds 183,170 shares of Class A common stock, which includes 41,668 shares of restricted stock vesting on April 25, 2027. He also holds equity awards covering additional Class A shares, including 50,000 underlying shares from stock appreciation rights exercisable at $5.80 per share expiring May 16, 2033, and several blocks of restricted stock units totaling 41,668, 51,213, and 121,792 underlying shares with scheduled vesting dates through 2028.

Rhea-AI Summary

Cineverse Corp. Chief Motion Pictures Officer Yolanda Macias reported equity award activity involving company stock. On May 1, 2026, she exercised 25,607 restricted stock units, converting them into the same number of Class A common shares at a stated exercise price of $0.00 per share.

To cover tax obligations related to this vesting, 13,895 Class A shares were disposed of as a tax-withholding transaction at $2.62 per share, rather than an open-market sale. After these transactions, she holds 129,909 Class A common shares directly and 146 shares indirectly through a minor child.

Macias also continues to hold a significant package of equity awards, including restricted stock units and stock appreciation rights tied to Class A common stock, with underlying share amounts such as 76,879 RSU-linked shares, 33,334 RSU-linked shares, and stock appreciation rights over 25,000 and 30,000 shares at exercise prices of $5.80 and $12.80, respectively.

Rhea-AI Summary

Cineverse Corp. executive Mark Antonio Huidor, President of Technology and Chief Product Officer, reported compensation-related equity activity in Class A common stock. On May 1, 2026, he exercised derivative securities to acquire 25,607 shares of common stock at an exercise price of $0.00 per share. On the same date, 13,461 shares of common stock were disposed of at $2.62 per share as a tax-withholding disposition, meaning shares were withheld to satisfy tax obligations rather than sold in the open market. After these transactions, he directly held 198,170 shares of Class A common stock. He also retained unexercised equity awards, including restricted stock units tied to 121,792 and 41,668 underlying shares, plus 50,000 stock appreciation rights exercisable at $5.80 per share expiring on May 16, 2033, with future vesting schedules extending through 2028.

Rhea-AI Summary

Cineverse Corp. chief legal officer Gary S. Loffredo reported routine equity compensation activity involving Class A common stock and related awards. He exercised restricted stock units covering 25,607 shares of Class A common stock at $0.00 per share, increasing his share ownership. To cover tax obligations, 11,727 shares of Class A common stock were withheld at $2.62 per share through a tax-withholding disposition, which is not an open-market sale. Following these transactions, he directly holds 214,498 shares of Class A common stock and maintains several unexercised restricted stock unit and stock appreciation right awards that are scheduled to vest over multiple future dates.

Rhea-AI Summary

Erick Opeka, CSO and President of Cineverse Corp., had 31,517 restricted stock units convert into the same number of Class A common shares on May 1, 2026. On that date, 13,832 shares were disposed in a tax-withholding transaction at $2.6200 per share. After these events, he directly holds 242,009 Class A shares, 253,013 restricted stock units, and stock appreciation rights over 152,750 underlying shares.

Rhea-AI Summary

Cineverse Corp. director, CEO and Chairman Christopher J. McGurk reported an update to his equity holdings, including an option-style transaction. He exercised derivative securities labeled as restricted stock units to acquire 40,000 shares of Class A common stock at a stated price of $0.0000 per share, increasing his direct ownership of common stock to 582,519 shares.

He also reports 178,526 shares of Class A common stock held indirectly through the Christopher and Jamie McGurk Living Trust, where he serves as trustee. In addition, he continues to hold several derivative awards tied to Class A common stock, including restricted stock units covering 263,006 and 50,000 underlying shares and stock appreciation rights over 125,000, 125,000 and 35,000 underlying shares at exercise prices of $9.60, $10.80 and $29.40 with stated vesting and expiration schedules.

Rhea-AI Summary

Cineverse Corp. Chief People Officer Mark Torres reported compensation-related equity activity involving restricted stock units and stock appreciation rights tied to Class A common stock. On May 1, 2026, he exercised derivatives to acquire 25,607 shares of Class A common stock at an exercise price of $0.00 per share, recorded as a derivative exercise/conversion.

To cover tax obligations on this vesting, 13,941 shares of Class A common stock were disposed of at $2.62 per share through a tax-withholding disposition, which is not an open-market sale. Following these transactions, Torres directly held 205,165 shares of Class A common stock.

The filing also shows remaining derivative positions, including restricted stock units and stock appreciation rights over additional Class A common shares, with portions scheduled to vest between 2024 and 2028. These events reflect routine equity compensation mechanics rather than discretionary open-market buying or selling.

Rhea-AI Summary

Cineverse Corp. Pres Tech/Chief Product Officer Mark Antonio Huidor reported routine equity compensation activity. He exercised 41,666 shares of Class A common stock from restricted stock units at $0.00 per share, while 45,703 shares were withheld to cover tax obligations at a value of $2.39 per share. After these transactions, he directly held 186,024 shares of Class A common stock.

He also continues to hold equity awards, including restricted stock units linked to 121,792 and 76,820 underlying Class A shares, and a stock appreciation right over 50,000 shares with a $5.80 exercise price expiring on May 16, 2033. Footnotes describe staggered vesting dates for these awards in 2026–2028.

Rhea-AI Summary

Cineverse Corp. Chief People Officer Mark Torres reported equity compensation activity involving Class A common stock and related awards. On April 25, 2026, he exercised 33,333 restricted stock units into Class A common stock at an exercise price of $0.00 per share. In a separate transaction the same day, 37,049 shares of Class A common stock were disposed of at $2.39 per share as a tax-withholding disposition, meaning the shares were withheld to satisfy tax liabilities rather than sold on the open market. Following these transactions, Torres directly owned 179,558 shares of Class A common stock. He also continued to hold derivative awards, including restricted stock units tied to 66,763 and 76,820 underlying Class A shares, and stock appreciation rights for 12,500 shares at an exercise price of $5.80 expiring on May 16, 2033, and 8,334 shares at $39.40 expiring on February 17, 2031.

Rhea-AI Summary

Cineverse Corp. CEO and Chairman Christopher McGurk exercised 50,000 restricted stock units into 50,000 shares of Class A common stock at $0 per share on April 25, 2026. After this derivative exercise, he holds 542,519 Class A shares directly.

He also has 178,526 Class A shares held indirectly through the Christopher and Jamie McGurk Living Trust. In addition, he retains equity awards including 263,006 and 120,000 restricted stock units and stock appreciation rights over 125,000 shares at $9.60, 125,000 shares at $10.80, and 35,000 shares at $29.40, with expirations between 2028 and 2032.

Rhea-AI Summary

Cineverse Corp. executive Erick Opeka, CSO and President, reported routine equity compensation activity involving restricted stock units and stock appreciation rights. On April 25, 2026, he exercised 45,833 RSUs into Class A common stock at $0.00 per share, and 45,655 shares of Class A common stock were surrendered in an F-code tax-withholding disposition at $2.39 per share to cover tax obligations, not as an open-market sale. Following these transactions, he directly owned 224,324 shares of Class A common stock and retained multiple derivative positions, including RSUs tied to 144,147 and 94,550 underlying shares and stock appreciation rights over additional shares with exercise prices of $5.80, $12.80, and $23.20 that vest over several years.

Rhea-AI Summary

Cineverse Corp. CFO Mark Lindsey reported compensation-related equity activity involving Class A common stock and equity awards. He exercised 33,333 restricted stock units, receiving the equivalent number of Class A shares at a conversion price of $0.00 per share. To cover tax obligations, 33,530 shares of Class A common stock were disposed of at $2.39 per share through a tax-withholding arrangement rather than an open-market sale, leaving 153,971 shares of Class A common stock held directly. He also continues to hold unexercised awards, including restricted stock units tied to 70,809 and 71,699 underlying Class A shares, plus 20,000 stock appreciation rights with an exercise price of $11.95 per share expiring in 2032. Footnotes indicate these RSUs and stock appreciation rights vest over multiple future dates in 2026–2028.

Rhea-AI Summary

Cineverse Corp. Chief Motion Pictures Officer Yolanda Macias reported routine equity compensation activity involving restricted stock units and related tax withholding. On April 25, 2026, she exercised 33,333 restricted stock units, each converting into one share of Class A common stock at an exercise price of $0.00 per share.

In a related F-code tax-withholding disposition, 36,896 shares of Class A common stock were withheld at $2.39 per share to satisfy tax obligations, rather than sold in the open market. She also reports indirect ownership of 146 Class A shares held by a minor child and continues to hold several unexercised restricted stock unit and stock appreciation right awards tied to Class A common stock.

Rhea-AI Summary

Cineverse Corp. chief legal officer Gary S. Loffredo reported compensation-related equity activity. He exercised 33,333 restricted stock units into Class A common stock and had 33,052 shares of Class A common stock withheld to cover tax obligations. Following these transactions, he directly owns 200,618 shares of Class A common stock. He also continues to hold a substantial package of equity awards, including restricted stock units tied to 130,289 and 76,820 underlying shares and stock appreciation rights over 40,000, 60,000, and 20,380 underlying shares at exercise prices of $5.80, $12.80, and $29.40.

Rhea-AI Summary

McCabe Sean William reported acquisition or exercise transactions in this Form 4 filing.

Cineverse Corp. CFO Sean William McCabe received a grant of 50,000 restricted stock units tied to Class A common stock. Each unit represents one share. According to the vesting schedule, 16,666 RSUs vest on April 20 of 2027 and 2028, and 16,668 vest on April 20, 2029. Following this award, McCabe holds 50,000 derivative units directly.

Rhea-AI Summary

Cineverse Corp. executive Mark Antonio Huidor, the company’s Pres Tech/Chief Product Off, purchased 37,500 shares of Class A common stock in an open-market transaction at $2.00 per share. The buy on February 17, 2026 totals about $75,000.

Following this purchase, he directly owns 190,061 shares of Class A common stock. He also holds stock appreciation rights covering 50,000 shares and multiple restricted stock unit awards that vest in tranches between 2026 and 2028, each unit equal to one share of Class A common stock.

Rhea-AI Summary

Cineverse Corp. CFO Lindsey Mark Wayne reported an open-market purchase of 35,000 shares of Class A common stock at $2.00 per share, increasing his direct holdings to 154,168 shares. This was a cash purchase in the market, rather than part of an automatic equity grant.

He also holds stock appreciation rights covering 20,000 shares and multiple blocks of restricted stock units, which vest over several years. Footnotes state that 66,667 restricted shares vest in two equal installments in April 2026 and April 2027, and additional RSUs vest annually between 2026 and 2028.

Rhea-AI Summary

Cineverse Corp.’s Chief Motion Pictures Officer, Yolanda Macias, reported mixed insider activity in Class A common stock. On February 17, 2026, she made an open‑market purchase of 30,000 shares at $2.00 per share, bringing her directly held stake to 121,760 shares.

The filing also references an earlier sale of 2,189 shares at $2.42 per share on December 2, 2025. A footnote states this sale was matchable with the new purchase for Section 16(b) short‑swing purposes, and she paid $919.38 to Cineverse, representing the full profit on that short‑swing transaction. Additional footnotes describe existing restricted stock, restricted stock units, and stock appreciation rights that vest in stages between 2026 and 2028, further tying her compensation to Cineverse’s equity.

Rhea-AI Summary

Cineverse Corp. Chief People Officer Mark Torres reported an open‑market purchase of 25,000 shares of Class A common stock at $2.0000 per share on February 17, 2026, bringing his directly held common stock to 183,274 shares.

He also reports direct holdings of stock appreciation rights and restricted stock units that vest over time. Footnotes state 66,667 restricted shares vest in tranches on April 25, 2026 and April 25, 2027, and various stock appreciation rights and RSUs vest on specified dates in 2024–2028.

Rhea-AI Summary

Cineverse Corp. reported that a trust associated with CEO and Chairman Christopher McGurk bought 75,000 shares of Class A common stock at $2.00 per share on February 17, 2026, raising its indirect holdings to 178,526 shares. The filing also details McGurk’s existing stock appreciation rights and restricted stock units that vest in stages through 2028.

Rhea-AI Summary

Cineverse Corp. chief legal officer Gary S. Loffredo bought 30,000 shares of Class A common stock in an open‑market purchase at $2.00 per share. After this trade, he directly owns 200,337 shares. He also holds stock appreciation rights and restricted stock units that vest in tranches through 2028.

Rhea-AI Summary

Cineverse Corp. executive Erick Opeka, the CSO and President, purchased 30,000 shares of Class A common stock in an open-market transaction at $2.00 per share. This buy on February 17, 2026 increased his directly owned common stock to 224,146 shares.

He also holds multiple grants of stock appreciation rights and restricted stock units, with footnotes showing scheduled vesting of rights and RSUs between 2026 and 2028, including tranches vesting on April 25 and May 1 in various years.

Rhea-AI Summary

Cineverse Corp. reported an insider equity transaction by one of its directors. On 12/08/2025, the director acquired 32,413 shares of Class A common stock at a stated price of $0, as part of the stock portion of the annual board retainer for the service year beginning October 1, 2025.

After this grant, the director beneficially owns 160,906 shares of Cineverse Class A common stock in direct ownership. The granted shares vest in four quarterly installments on December 31, 2025, March 31, 2026, June 30, 2026 and September 30, 2026, provided the director continues to serve on the board on each vesting date.

Rhea-AI Summary

Cineverse Corp. director reports equity compensation grant

A Cineverse Corp. director reported receiving 32,413 shares of Class A common stock on December 8, 2025. This stock represents the equity portion of the director’s annual board retainer for the service year commencing October 1, 2025. The shares vest in four equal quarterly installments on December 31, 2025, March 31, 2026, June 30, 2026 and September 30, 2026, subject to the director continuing to serve on the board on each vesting date.

Following this grant, the director is shown as beneficially owning 160,361 Class A common shares directly and 4,603 shares indirectly through Grassmere Partners, LLC, where he is Chairman. He disclaims beneficial ownership of the indirectly held shares except to the extent of any pecuniary interest.

Rhea-AI Summary

Mark W. Lindsey, Chief Financial Officer of Cineverse Corp. (CNVS) reported changes in his holdings on 10/08/2025. The filing shows a disposition of 119,168 shares of Class A common stock, leaving him with several categories of equity awards: outstanding stock appreciation rights exercisable at $11.95 covering 20,000 underlying shares, and multiple restricted stock units (RSUs) and a separate RSU grant that together total 209,175 underlying Class A shares across different vesting schedules. One RSU tranche of 70,809 shares was reported as acquired on 10/08/2025 at $0 (i.e., newly granted).

The disclosure itemizes vesting timelines: portions of RSUs vest in 2026, 2027, and 2028, and SAR vesting dates include 11/14/2023 through 11/14/2025. The mix of a cashless/zero-price grant and multi-year vesting schedules indicates continued equity compensation tied to future service.

Rhea-AI Summary

Insider transfer reported by Cineverse Corp. officer Yolanda Macias. The filing shows Ms. Macias holds 93,949 Class A shares indirectly and reports a disposition of 93,949 Class A shares plus an indirect 146 share holding for a minor child. She also holds multiple equity awards: two stock appreciation rights covering 30,000 and 25,000 shares with exercise prices of $12.8 and $5.8, and restricted stock units (RSUs) totaling 305,253 underlying Class A shares across several grants. A grant of 79,879 RSUs was reported as acquired on 10/08/2025 with $0 price; portions of RSUs vest annually through 10/08/2028 and other grants vest through 05/01/2028 and 04/25/2027.

Rhea-AI Summary

Christopher J. McGurk, CEO and Chairman of Cineverse Corp. (CNVS), reported changes in his beneficial ownership on 10/08/2025. He acquired 263,006 restricted stock units (RSUs) that convert one-for-one into Class A common stock and now directly holds 263,006 shares from that grant. The filing also shows 103,526 Class A shares held indirectly via the Christopher and Jamie McGurk Living Trust and a reported disposition of 492,519 Class A shares. McGurk retains multiple stock appreciation rights and prior RSUs/awards: 35,000, 125,000, and 125,000 SARs at exercise prices of $29.4, $10.8, and $9.6 respectively, plus outstanding RSUs totaling 220,000 that vest on scheduled future dates. Vesting schedules for the awards are disclosed through 10/08/2028.

Rhea-AI Summary

Insider transaction summary for Cineverse Corp. (CNVS): The reporting officer, Mark Antonio Huidor, reported a disposal and several derivative/award holdings. On 10/08/2025 he disposed of 152,561 shares of Class A common stock. Following that transaction his direct holdings include vested and unvested equity awards: a $5.8 strike stock appreciation right exercisable into 50,000 shares, and multiple restricted stock units (RSUs) and other awards totaling 382,746 Class A shares equivalent (sum of listed amounts). A newly acquired grant of 121,792 RSUs was recorded with $0 per-share price and vesting scheduled across 2026–2028. The filing shows staged vesting dates for existing awards.

Rhea-AI Summary

Cineverse Corp. (CNVS) reported an insider equity award on a Form 4. The company’s Chief People Officer received 66,763 restricted stock units (RSUs) on 10/08/2025 (transaction code A, price $0). These RSUs vest in three equal-year tranches: 22,254 on October 8, 2026, 22,254 on October 8, 2027, and 22,255 on October 8, 2028.

Following the reported transactions, the officer beneficially owned 158,274 shares of Class A common stock directly. Derivative holdings include stock appreciation rights for 8,334 shares (exercise price $39.4, expiring 02/17/2031) and 12,500 shares (exercise price $5.8, expiring 05/16/2033), plus other RSUs of 66,667 and 76,820 with stated vesting schedules.

Rhea-AI Summary

Erick Opeka, CSO and President of Cineverse Corp. (CNVS), reported multiple equity changes on 10/08/2025. The filing shows a disposition of 194,146 shares of Class A common stock and the acquisition/vesting of 144,147 restricted stock units into Class A common stock at no cash cost. The report lists outstanding stock appreciation rights with strike prices of $23.2, $12.8, and $5.8 covering 17,750, 60,000, and 75,000 underlying shares respectively. Several previously granted restricted stock units and appreciation rights have scheduled vesting dates between 2024 and 2028, with specific RSU tranches vesting in 2026, 2027, and 2028.

Rhea-AI Summary

Gary S. Loffredo, Chief Legal Officer, Secretary and Senior Advisor at Cineverse Corp. (CNVS), filed a Form 4 reporting multiple equity changes on 10/08/2025. The filing shows a disposition of 170,337 shares of Class A common stock and the grant or settlement of 130,289 restricted stock units (RSUs) that were reported as acquired at $0. In addition, the filing lists existing stock appreciation rights (SARs) and RSUs totaling 203,867 underlying Class A shares across several award tranches with exercise prices of $29.4, $12.8 and $5.8 and multiple staggered vesting schedules through 2033. The document clarifies vesting timetables for legacy SARs and newly reported RSUs, indicating staged vesting dates in 2026, 2027 and 2028.

Rhea-AI Summary

Mark W. Lindsey, CFO of Cineverse Corp. (CNVS), reported changes in his beneficial ownership on Form 4. The filing shows a disposition of 119,168 shares of Class A common stock on 09/23/2025. It also reports outstanding equity awards: a Stock Appreciation Right exercisable at $11.95 covering 20,000 underlying shares expiring 11/14/2032, and multiple Restricted Stock Units (RSUs) totaling 138,366 RSUs across different grant schedules that vest between 2025 and 2028. Specific vesting schedules are included for each award.